Companies included in IBBQ Page 2
This is IBBQ's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 101–200 of 267.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 7,358 | NS | 0.137654% |
| BCRX | BioCryst Pharmaceuticals, Inc. | 11,766 | NS | 0.135924% |
| PHVS | Pharvaris N.V. | 3,591 | NS | 0.134599% |
| VCEL | Vericel Corp. | 2,833 | NS | 0.133454% |
| RLAY | Relay Therapeutics, Inc. | 9,680 | NS | 0.131124% |
| ELVN | Enliven Therapeutics, Inc. | 3,328 | NS | 0.130453% |
| TYRA | Tyra Biosciences, Inc. | 2,966 | NS | 0.130439% |
| AGIO | Agios Pharmaceuticals, Inc. | 3,239 | NS | 0.129274% |
| SRPT | Sarepta Therapeutics, Inc. | 5,837 | NS | 0.129159% |
| ZYME | Zymeworks Inc. | 4,184 | NS | 0.128653% |
| DFTX | Definium Therapeutics, Inc. | 5,503 | NS | 0.126781% |
| INVA | Innoviva, Inc. | 4,181 | NS | 0.12674% |
| Genmab A/S | Genmab A/S | 3,245 | NS | 0.126128% |
| ANIP | ANI Pharmaceuticals, Inc. | 1,263 | NS | 0.123228% |
| AMLX | Amylyx Pharmaceuticals, Inc. | 6,115 | NS | 0.122474% |
| ORKA | Oruka Therapeutics, Inc. | 2,692 | NS | 0.122298% |
| NVAX | Novavax, Inc. | 9,091 | NS | 0.121705% |
| SION | Sionna Therapeutics, Inc. | 2,514 | NS | 0.121281% |
| HRMY | Harmony Biosciences Holdings, Inc. | 3,206 | NS | 0.120803% |
| NRIX | Nurix Therapeutics, Inc. | 5,681 | NS | 0.119782% |
| RAPT Therapeutics, Inc. | RAPT Therapeutics, Inc. | 1,551 | NS | 0.118727% |
| LEGN | Legend Biotech Corp. | 4,707 | NS | 0.118075% |
| ARDX | Ardelyx, Inc. | 13,580 | NS | 0.117436% |
| NTLA | Intellia Therapeutics, Inc. | 6,453 | NS | 0.117401% |
| NVCR | NovoCure Ltd. | 6,261 | NS | 0.112998% |
| ANAB | AnaptysBio, Inc. | 1,550 | NS | 0.112655% |
| IOVA | Iovance Biotherapeutics, Inc. | 22,091 | NS | 0.11258% |
| TRVI | Trevi Therapeutics, Inc. | 7,146 | NS | 0.11246% |
| TNGX | Tango Therapeutics Inc. | 7,535 | NS | 0.110823% |
| MBX | MBX Biosciences, Inc. | 2,526 | NS | 0.108554% |
| EYPT | EyePoint, Inc. | 4,637 | NS | 0.107503% |
| KOD | Kodiak Sciences Inc. | 2,951 | NS | 0.104415% |
| IMCR | Immunocore Holdings PLC | 2,432 | NS | 0.103711% |
| ZBIO | Zenas Biopharma, Inc. | 2,980 | NS | 0.103671% |
| RAPP | Rapport Therapeutics, Inc. | 2,657 | NS | 0.101835% |
| CRVS | Corvus Pharmaceuticals, Inc. | 4,177 | NS | 0.100699% |
| PGEN | Precigen, Inc. | 19,747 | NS | 0.09881% |
| COLL | Collegium Pharmaceutical, Inc. | 1,776 | NS | 0.097707% |
| ATAI | AtaiBeckley Inc. | 20,269 | NS | 0.09714% |
| ORIC | ORIC Pharmaceuticals, Inc. | 5,451 | NS | 0.096796% |
| SEPN | Septerna, Inc. | 2,520 | NS | 0.096551% |
| VIR | Vir Biotechnology, Inc. | 7,785 | NS | 0.093429% |
| Alvotech | Alvotech | 17,492 | NS | 0.092145% |
| TSHA | Taysha Gene Therapies Inc. | 15,289 | NS | 0.09144% |
| SVRA | Savara Inc. | 11,348 | NS | 0.090194% |
| GLUE | Monte Rosa Therapeutics, Inc. | 3,640 | NS | 0.085302% |
| SANA | Sana Biotechnology, Inc. | 14,886 | NS | 0.082741% |
| Grifols, S.A. | Grifols, S.A. | 6,813 | NS | 0.081854% |
| PAHC | Phibro Animal Health Corp. | 1,124 | NS | 0.08101% |
| Day One Biopharmaceuticals, Inc. | Day One Biopharmaceuticals, Inc. | 5,740 | NS | 0.08033% |
| ABCL | AbCellera Biologics Inc. | 16,724 | NS | 0.079709% |
| GERN | Geron Corp. | 35,647 | NS | 0.079067% |
| INBX | Inhibrx Biosciences, Inc. | 807 | NS | 0.078982% |
| URGN | UroGen Pharma Ltd. | 2,613 | NS | 0.074862% |
| XERS | Xeris Biopharma Holdings, Inc. | 9,253 | NS | 0.074764% |
| MNKD | MannKind Corp. | 17,136 | NS | 0.074207% |
| Ventyx Biosciences, Inc. | Ventyx Biosciences, Inc. | 3,977 | NS | 0.073352% |
| FTRE | Fortrea Holdings Inc. | 5,176 | NS | 0.073257% |
| QURE | uniQure N.V. | 3,468 | NS | 0.071565% |
| AVBP | ArriVent Biopharma, Inc. | 2,313 | NS | 0.070145% |
| PCRX | Pacira Biosciences, Inc. | 2,398 | NS | 0.069367% |
| AMPH | Amphastar Pharmaceuticals, Inc. | 2,574 | NS | 0.068749% |
| TBPH | Theravance Biopharma Inc. | 2,837 | NS | 0.068357% |
| BCAX | Bicara Therapeutics Inc. | 3,072 | NS | 0.068057% |
| CGEM | Cullinan Therapeutics, Inc. | 3,316 | NS | 0.067859% |
| GHRS | GH Research PLC | 3,456 | NS | 0.067758% |
| SPRY | ARS Pharmaceuticals, Inc. | 5,518 | NS | 0.067607% |
| XNCR | Xencor, Inc. | 3,980 | NS | 0.067102% |
| CTMX | CytomX Therapeutics, Inc. | 9,460 | NS | 0.06707% |
| ABUS | Arbutus Biopharma Corp. | 10,743 | NS | 0.066096% |
| PHAT | Phathom Pharmaceuticals, Inc. | 3,967 | NS | 0.065783% |
| CSTL | Castle Biosciences, Inc. | 1,619 | NS | 0.063206% |
| ARVN | Arvinas, Inc. | 3,599 | NS | 0.063054% |
| OMER | Omeros Corp. | 3,957 | NS | 0.062953% |
| PRME | Prime Medicine, Inc. | 10,067 | NS | 0.061405% |
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | 2,831 | NS | 0.060849% |
| JANX | Janux Therapeutics, Inc. | 3,365 | NS | 0.060465% |
| ANNX | Annexon, Inc. | 8,089 | NS | 0.059806% |
| PSNL | Personalis, Inc. | 4,964 | NS | 0.059377% |
| BIOA | BioAge Labs, Inc. | 2,018 | NS | 0.059334% |
| Esperion Therapeutics, Inc. | Esperion Therapeutics, Inc. | 13,354 | NS | 0.059063% |
| Mesoblast Ltd. | Mesoblast Ltd. | 2,721 | NS | 0.05694% |
| KURA | Kura Oncology, Inc. | 4,878 | NS | 0.056223% |
| ZLAB | Zai Lab Ltd. | 2,174 | NS | 0.055166% |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio | 39,488.05 | NS | 0.052135% |
| CMPS | COMPASS Pathways PLC | 5,259 | NS | 0.047909% |
| RIGL | Rigel Pharmaceuticals, Inc. | 1,019 | NS | 0.046737% |
| ALLO | Allogene Therapeutics, Inc. | 12,556 | NS | 0.046085% |
| MGTX | MeiraGTx Holdings PLC | 4,490 | NS | 0.044816% |
| REPL | Replimune Group, Inc. | 4,391 | NS | 0.044349% |
| DSGN | Design Therapeutics, Inc. | 3,177 | NS | 0.04379% |
| NMRA | Neumora Therapeutics, Inc. | 9,348 | NS | 0.043073% |
| CRMD | CorMedix Inc. | 4,414 | NS | 0.041551% |
| IRWD | Ironwood Pharmaceuticals, Inc. | 9,099 | NS | 0.041085% |
| FDMT | 4D Molecular Therapeutics, Inc. | 3,185 | NS | 0.040621% |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | 6,041 | NS | 0.039958% |
| VNDA | Vanda Pharmaceuticals Inc. | 3,317 | NS | 0.03902% |
| LXEO | Lexeo Therapeutics, Inc. | 4,094 | NS | 0.038809% |
| LYEL | Lyell Immunopharma, Inc. | 1,207 | NS | 0.038245% |
| MRVI | Maravai LifeSciences Holdings, Inc. | 8,103 | NS | 0.038085% |
SEC N-PORT snapshot as of .